These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 15448686
21. IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection. Colpitts SL, Dalton NM, Scott P. J Immunol; 2009 May 01; 182(9):5702-11. PubMed ID: 19380817 [Abstract] [Full Text] [Related]
23. The early generation of a heterogeneous CD4+ T cell response to Leishmania major. Colpitts SL, Scott P. J Immunol; 2010 Aug 15; 185(4):2416-23. PubMed ID: 20624946 [Abstract] [Full Text] [Related]
24. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells. Bertholet S, Debrabant A, Afrin F, Caler E, Mendez S, Tabbara KS, Belkaid Y, Sacks DL. Infect Immun; 2005 Oct 15; 73(10):6620-8. PubMed ID: 16177338 [Abstract] [Full Text] [Related]
29. Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis. Okwor I, Liu D, Uzonna J. Vaccine; 2009 Apr 28; 27(19):2554-62. PubMed ID: 19428861 [Abstract] [Full Text] [Related]
34. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Sallusto F, Lanzavecchia A. Eur J Immunol; 2009 Aug 28; 39(8):2076-82. PubMed ID: 19672903 [Abstract] [Full Text] [Related]
35. Role of T cell subsets during the recall of immunologic memory to Leishmania major. Müller I. Eur J Immunol; 1992 Dec 28; 22(12):3063-9. PubMed ID: 1359969 [Abstract] [Full Text] [Related]
36. Memory CD4 T cells emerge from effector T-cell progenitors. Harrington LE, Janowski KM, Oliver JR, Zajac AJ, Weaver CT. Nature; 2008 Mar 20; 452(7185):356-60. PubMed ID: 18322463 [Abstract] [Full Text] [Related]
39. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection. Rosas LE, Barbi J, Lu B, Fujiwara Y, Gerard C, Sanders VM, Satoskar AR. Eur J Immunol; 2005 Feb 20; 35(2):515-23. PubMed ID: 15668916 [Abstract] [Full Text] [Related]
40. Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation. Louis J, Gumy A, Voigt H, Röcken M, Launois P. Eur J Dermatol; 2002 Feb 20; 12(4):316-8. PubMed ID: 12095873 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]